Cristina Nombela Otero
Cristina Nombela Otero
Dpto. Psicología Biológica y de la Salud. Universidad Autónoma de Madrid
Verified email at
Cited by
Cited by
Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study
AJ Yarnall, DP Breen, GW Duncan, TK Khoo, SY Coleman, MJ Firbank, ...
Neurology 82 (4), 308-316, 2014
Into the groove: can rhythm influence Parkinson's disease?
C Nombela, LE Hughes, AM Owen, JA Grahn
Neuroscience & Biobehavioral Reviews 37 (10), 2564-2570, 2013
Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study
C Nombela, JB Rowe, SE Winder-Rhodes, A Hampshire, AM Owen, ...
Brain 137 (10), 2743-2758, 2014
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson’s disease
Z Ye, E Altena, C Nombela, CR Housden, H Maxwell, T Rittman, ...
Brain 137 (4), 1145-1155, 2014
Cognitive rehabilitation in Parkinson’s disease: evidence from neuroimaging
C Nombela, PJ Bustillo, PF Castell, L Sanchez, V Medina, MT Herrero
Frontiers in neurology 2, 82, 2011
Improving response inhibition in Parkinson’s disease with atomoxetine
Z Ye, E Altena, C Nombela, CR Housden, H Maxwell, T Rittman, ...
Biological Psychiatry 77 (8), 740-748, 2015
Multiple modes of impulsivity in Parkinson's disease
C Nombela, T Rittman, TW Robbins, JB Rowe
PloS one 9 (1), e85747, 2014
Atomoxetine restores the response inhibition network in Parkinson’s disease
CL Rae, C Nombela, PV Rodríguez, Z Ye, LE Hughes, PS Jones, T Ham, ...
Brain 139 (8), 2235-2248, 2016
Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson’s disease
J Zhang, T Rittman, C Nombela, A Fois, I Coyle-Gilchrist, RA Barker, ...
Brain 139 (1), 161-173, 2016
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in P arkinson's disease with clinical and neuroimaging measures
Z Ye, CL Rae, C Nombela, T Ham, T Rittman, PS Jones, PV Rodríguez, ...
Human brain mapping 37 (3), 1026-1037, 2016
Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease
DP Breen, C Nombela, R Vuono, PS Jones, K Fisher, DJ Burn, DJ Brooks, ...
Movement Disorders 31 (7), 1062-1066, 2016
Personalized striatal targets for deep brain stimulation in obsessive-compulsive disorder
JA Barcia, JM Avecillas-Chasín, C Nombela, R Arza, J García-Albea, ...
Brain stimulation 12 (3), 724-734, 2019
Atomoxetine enhances connectivity of prefrontal networks in Parkinson’s disease
RJ Borchert, T Rittman, L Passamonti, Z Ye, S Sami, SP Jones, ...
Neuropsychopharmacology 41 (8), 2171-2177, 2016
Sensory attenuation in Parkinson’s disease is related to disease severity and dopamine dose
N Wolpe, J Zhang, C Nombela, JN Ingram, DM Wolpert, JB Rowe
Scientific Reports 8 (1), 1-10, 2018
How often does music and rhythm improve patients’ perception of motor symptoms in Parkinson’s disease?
C Nombela, CL Rae, JA Grahn, RA Barker, AM Owen, JB Rowe
Journal of neurology 260 (5), 1404-1405, 2013
Alpha-theta effects associated with ageing during the Stroop test
C Nombela, M Nombela, P Castell, T García, J López-Coronado, ...
PloS one 9 (5), e95657, 2014
Time on timing: dissociating premature responding from interval sensitivity in Parkinson's disease
J Zhang, C Nombela, N Wolpe, RA Barker, JB Rowe
Movement Disorders 31 (8), 1163-1172, 2016
Inflammatory response in Parkinsonism
C Barcia, F Ros, M Angeles Carrillo, D Aguado-Llera, CM Ros, A Gómez, ...
Birth, Life and Death of Dopaminergic Neurons in the Substantia Nigra, 245-252, 2009
Dopaminergic modulation of positive expectations for goal-directed action: evidence from Parkinson’s disease
N Wolpe, C Nombela, JB Rowe
Frontiers in psychology 6, 1514, 2015
Stimulation of the tractography-defined subthalamic nucleus regions correlates with clinical outcomes
JM Avecillas-Chasin, F Alonso-Frech, C Nombela, C Villanueva, ...
Neurosurgery 85 (2), E294-E303, 2019
The system can't perform the operation now. Try again later.
Articles 1–20